Engineering yeast for industrial-level production of the antimalarial drug artemisinin

被引：2
|
作者：
Smith, Ayoola B. [1 ]
Chekan, Jonathan R. [2 ]
机构：
[1] Univ North Carolina Greensboro, Dept Nanosci, Greensboro, NC USA
[2] Univ North Carolina Greensboro, Dept Chem & Biochem, Greensboro, NC 27412 USA
来源：
TRENDS IN BIOTECHNOLOGY | 2023年 / 41卷 / 03期
关键词：
SYNTHETIC BIOLOGY; ACID;
D O I：
10.1016/j.tibtech.2022.12.007
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Artemisinin-based combination therapies are the gold standard treatment for uncomplicated malaria. A seminal study by Paddon et al. detailed an efficient approach for producing artemisinic acid from engineered yeast and its conversion to artemisinin, and demonstrated how to use metabolic engineering and synthetic biology for the production of bioactive compounds.
引用
收藏
页码：267 / 269
页数：3
相关论文
共 50 条
  • [1] Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug
    Chunzhao Liu
    Yan Zhao
    Yuchun Wang
    Applied Microbiology and Biotechnology, 2006, 72 : 11 - 20
  • [2] Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug
    Liu, Chunzhao
    Zhao, Yan
    Wang, Yuchun
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2006, 72 (01) : 11 - 20
  • [3] Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens
    Ikram, Nur Kusaira Binti Khairul
    Kashkooli, Arman Beyraghdar
    Peramuna, Anantha Vithakshana
    van der Krol, Alexander R.
    Bouwmeester, Harro
    Simonsen, Henrik Toft
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2017, 5
  • [4] Systematic metabolic engineering of Corynebacterium glutamicum for the industrial-level production of optically pure D-(-)-acetoin
    Mao, Yufeng
    Fu, Jing
    Tao, Ran
    Huang, Can
    Wang, Zhiwen
    Tang, Ya-Jie
    Chen, Tao
    Zhao, Xueming
    GREEN CHEMISTRY, 2017, 19 (23) : 5691 - 5702
  • [5] Drug resistance genomics of the antimalarial drug artemisinin
    Winzeler, Elizabeth A.
    Manary, Micah J.
    GENOME BIOLOGY, 2014, 15 (11):
  • [6] Drug resistance genomics of the antimalarial drug artemisinin
    Elizabeth A Winzeler
    Micah J Manary
    Genome Biology, 15
  • [7] Artemisinin, a novel antimalarial drug: Biochemical and molecular approaches for enhanced production
    Abdin, MZ
    Israr, M
    Rehman, RU
    Jain, SK
    PLANTA MEDICA, 2003, 69 (04) : 289 - 299
  • [8] Alkylation of heme by artemisinin, an antimalarial drug
    Cazelles, J
    Robert, A
    Meunier, B
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE, 2001, 4 (02): : 85 - 89
  • [9] Alkylation of heme by the antimalarial drug artemisinin
    Robert, A
    Coppel, Y
    Meunier, B
    CHEMICAL COMMUNICATIONS, 2002, (05) : 414 - 415
  • [10] Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin
    Westfall, Patrick J.
    Pitera, Douglas J.
    Lenihan, Jacob R.
    Eng, Diana
    Woolard, Frank X.
    Regentin, Rika
    Horning, Tizita
    Tsuruta, Hiroko
    Melis, David J.
    Owens, Andrew
    Fickes, Scott
    Diola, Don
    Benjamin, Kirsten R.
    Keasling, Jay D.
    Leavell, Michael D.
    McPhee, Derek J.
    Renninger, Neil S.
    Newman, Jack D.
    Paddon, Chris J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (03) : 111 - 118
12345